MedPath

浙江华军药业有限公司

Ownership
-
Established
2015-12-08
Employees
-
Market Cap
-
Website
www.zjhjyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Thymopentin

Product Name
胸腺五肽
Approval Number
国药准字H20073942
Approval Date
Feb 14, 2023
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.